TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Tectonic Therapeutic, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$21.15+0.50 (+2.42%)
Close on Oct 19, 2026
- Market cap
- $401.09M
- P/E (TTM)
- –
- Dividend yield
- 0.00%